Back

Incidence of atrial fibrillation after haematopoietic stem cell transplantation: the COAST-AF study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Atrial fibrillation in complex patients Prevalence and Incidence of Atrial Fibrillation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Kseniya Bulatova

University Hospital Basel, Basel (Switzerland)

7 More presentations in this session

Presentation thumbnail
Discussant - Atrial fibrillation in complex patients
Presentation thumbnail
Association of pulse pressure with incidence of hospitalization for heart failure in atrial fibrillation patients without heart failure: the Fushimi AF Registry
Doctor Y. Tezuka (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Association between smoking habit change and the risk of new-onset atrial fibrillation in patients with diabetes mellitus: a nationwide observational cohort study
Assistant Professor K. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Right ventricular systolic function in atrial fibrillation
Ms A. Lizancos Castro (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Temporal dynamics of myocardial injury biomarkers during cellular electroporation: analysis of different pulsed-field ablation technologies versus radiofrequency ablation in atrial fibrillation
Associate Professor M. Casella (Ancona, IT)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Atrial fibrillation in complex patients

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Cardiovascular events and consequent risk of death in hematopoietic stem cell transplant recipients
thumbnail
Congress Presentation
A matter of inflammation: CAR T-cell therapy and atrial fibrillation
thumbnail
Congress Presentation
Predicting late cardiovascular events in allogeneic hematopoietic stem cell transplant recipients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources